Reliance Life Sciences Private Limited Bortezomib for Injection 3.5mg/Vial recall: Lack of Sterility Assurance
Lack of Sterility Assurance
The hazard: Sterility or particulate concern
The concern here is contamination of a product that bypasses the body’s normal defences, which is why the threshold for recalling it is low.
What the notice says: Lack of Sterility Assurance
Why it matters: The product was made or packaged in conditions that cannot assure sterility, or visible particles were found in it. For anything injected, infused or used in the eye, that is a direct route for contamination into the body.
Symptoms and when to call a doctor
Watch for fever, chills, pain, redness, swelling or discharge at an injection site, and for a red, painful or suddenly blurred eye after using an eye product. Any of these needs same-day medical attention. Do not wait to see whether it settles, and tell the clinician which product and lot you used so it can be reported against the recall.
This page is general information, not medical advice. If you feel unwell, a clinician who can see you is the only person able to judge your case.
Recall details
- Recall number
- D-0673-2026
- Published
- July 15, 2026
- Risk level
- Class II
- Status
- Ongoing
- Issued by
- U.S. Food and Drug Administration
- Brand
- Reliance Life Sciences Private Limited
- Product type
- Prescription & OTC drugs
- Units affected
- 11,400 vials
- Distribution
- Nationwide
- Made in
- India
- Lot / code info
- Lot, expiry: RBIH0125A Jan 31, 2028; RBIH0225A Feb 29, 2028; RBIH0325A Feb 29, 2028; RBIH0525A Mar 31, 2028
Products covered by this recall
Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873. NDC: 70069-0836-01
Check your product
The notice names 5 codes you can read straight off the package. Type the one printed on yours and the list below narrows to it.
Best-by / use-by date
Printed beside the lot code, not on the price sticker.
- RBIH0125A Jan 31
- 2028
NDC number
On the carton and again on the bottle or blister label.
- 70069-0836-01
Package size
Match the net weight or the piece count on the front of the pack.
- 3.5 mg
- 10 mL
Codes are lifted verbatim from the FDA — Drug enforcement notice. A code that is missing here may still be covered — the official notice is the complete list.
What to do about Sterility
Reliance Life Sciences Private Limited — The concern here is contamination of a product that bypasses the body’s normal defences, which is why the threshold for recalling it is low.
- Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
- Call your prescriber or pharmacy today about a replacement from an unaffected lot — do not simply skip doses of a medicine you depend on.
- If you are a clinic or pharmacy, quarantine the stock and work it through your usual recall log.
- Report any infection or reaction you think the product caused to FDA MedWatch.
Getting a replacement supply
Do not let a refund question interrupt your treatment. Deal with the supply first and the money second.
- Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
- Insurers do not normally count a recall replacement against a refill limit. If one is refused, ask the pharmacist to call it through as a recall override.
- Over-the-counter products are refunded at the till like any other purchase; the recall notice on your phone is enough to explain the return.
- If the manufacturer runs a direct reimbursement form, it will be linked from the official notice on this page.
Company contact: Reliance Life Sciences Private Limited — Ttc Area Of Midc, Navi Mumbai
The official notice
This page summarises a notice published by U.S. Food and Drug Administration. The agency notice is the authoritative version — read it before you act, and treat it as the final word if anything here looks different.
Open the FDA — Drug enforcement record U.S. Food and Drug Administration recalls
Questions people ask about this recall
Why was Reliance Life Sciences Private Limited prescription & otc… recalled?
Lack of Sterility Assurance Lack of Sterility Assurance
How do I know if I have the recalled product?
Match the codes printed on your package against the notice: best-by date RBIH0125A Jan 31 or 2028. If the code on your package is not on that list, your unit is outside the recall.
What should I do with it right now?
Stop using the affected lot and check the lot number on your own carton or vial against the codes listed above.
Can I get my money back?
Call the pharmacy before you run low. They can see which lot they dispensed to you and will usually swap it the same day.
Where was the recalled product sold?
It was distributed nationwide.
Related recalls
-
Class II · 3 months ago
Reliance Life Sciences Private Limited Pemetrexed for Injection 500mg/Vial recall: Lack of Sterility Assurance
Lack of Sterility Assurance
-
Class II · 3 months ago
Reliance Life Sciences Private Limited Pemetrexed for Injection 100mg/Vial recall: Lack of Sterility Assurance
Lack of Sterility Assurance
-
Class II · 3 months ago
Reliance Life Sciences Private Limited Azacitidine for Injection 100mg/Vial recall: Lack of Sterility Assurance
Lack of Sterility Assurance
-
Class II · 11 days ago
K.C. Pharmaceuticals, Inc. Sterile Lubricant Dry Eye Relief Eye Drops, 0.5 FL OZ recall: Lack of Assurance of Sterility
Lack of Assurance of Sterility
-
Class II · 11 days ago
Carolina Infusion, LLC Quad-Mix Injectable, Packaged in single-use dosage syringes recall: Lack of Assurance of Sterility: Related to processing equipment used
Lack of Assurance of Sterility: Related to processing equipment used in compounded product.
-
Class II · 11 days ago
Carolina Infusion, LLC Tirzepatide/Cyanocobalamin 26/2 MG/ML Injectable recall: Lack of Assurance of Sterility: Related to formulation using bacteriostic
Lack of Assurance of Sterility: Related to formulation using bacteriostic water; Related to processing equipment used in compounded product.